{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:55:05Z","timestamp":1777330505717,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jvc.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T02:18:45Z","timestamp":1557541125000},"page":"7-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study"],"prefix":"10.1016","volume":"24","author":[{"given":"J.A.","family":"Jaffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.R.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Wiggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Reinero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2019.05.001_bib1","first-page":"363","article-title":"World Health Organization group I pulmonary hypertension: epidemiology and pathophysiology","volume":"34","author":"Prins","year":"2016","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jvc.2019.05.001_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jvc.2012.01.001","article-title":"Pulmonary hypertension in canine degenerative mitral valve disease","volume":"14","author":"Kellihan","year":"2012","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cvsm.2010.03.011","article-title":"Pulmonary hypertension in dogs: diagnosis and therapy","volume":"40","author":"Kellihan","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.jvc.2019.05.001_bib4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/jvim.13609","article-title":"Diagnostic value of selected echocardiographic variables to identify pulmonary hypertension in dogs with myxomatous mitral valve disease","volume":"29","author":"Tidholm","year":"2015","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jvim.13820","article-title":"Prognostic value of right ventricular tei Index in dogs with myxomatous mitral valvular heart disease","volume":"30","author":"Nakamura","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib6","first-page":"440","article-title":"Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992-1996","volume":"13","author":"Johnson","year":"1999","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib7","first-page":"99","article-title":"Pulmonary hypertension and cardiovascular sequelae in 54 dogs","volume":"2","author":"Pyle","year":"2004","journal-title":"Intern J Appl Res Vet Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1939-1676.2006.tb00711.x","article-title":"Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs","volume":"20","author":"Bach","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1939-1676.2007.tb01947.x","article-title":"Sildenafil citrate therapy in 22 dogs with pulmonary hypertension","volume":"21","author":"Kellum","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib10","first-page":"1280","article-title":"Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension","volume":"21","author":"Serres","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.vetpar.2014.08.016","volume":"206","author":"Venco","year":"2014","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.jvc.2019.05.001_bib12","first-page":"99","article-title":"Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review","volume":"10","author":"Henrie","year":"2015","journal-title":"Core Evid"},{"key":"10.1016\/j.jvc.2019.05.001_bib13","first-page":"273","article-title":"The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension","volume":"6","author":"Falk","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jvc.2019.05.001_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1939-1676.2010.0517.x","article-title":"Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs","volume":"24","author":"Brown","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jvp.12487","article-title":"Pharmacokinetics of single-dose sildenafil administered orally in clinically healthy dogs: effect of feeding and dose proportionality","volume":"41","author":"Akabane","year":"2018","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.jvc.2019.05.001_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13318-014-0199-4","article-title":"Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs","volume":"40","author":"Al-Mohizea","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jvc.2019.05.001_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.clinthera.2011.06.008","article-title":"Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension","volume":"33","author":"Arif","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.jvc.2019.05.001_bib18","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib19","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2019.05.001_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1074248414528066","article-title":"Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study","volume":"19","author":"Frantz","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jvc.2019.05.001_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jvc.2019.05.001_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.117.245993","article-title":"In\u00a0vitro assessment of pharmacokinetic drug-drug interactions of direct oral anticoagulants: type 5-phosphodiesterase inhibitors are inhibitors of rivaroxaban and apixaban efflux by p-glycoprotein","volume":"365","author":"Margelidon-Cozzolino","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jvc.2019.05.001_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tvjl.2014.08.009","article-title":"Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension","volume":"202","author":"Hori","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.jvc.2019.05.001_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1439-0442.2006.00800.x","article-title":"Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog","volume":"53","author":"Serres","year":"2006","journal-title":"J Vet Med A Physiol Pathol Clin Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib25","article-title":"Comparison of tadalafil and sildenafil in controlling neonatal persistent pulmonary hypertension","volume":"27","author":"Alipour","year":"2017","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.jvc.2019.05.001_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jvim.13911","article-title":"Diagnostic value of right pulmonary artery distensibility index in dogs with pulmonary hypertension: comparison with Doppler echocardiographic estimates of pulmonary arterial pressure","volume":"30","author":"Visser","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib27","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, American College of veterinary internal medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.2460\/javma.229.11.1772","article-title":"Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005)","volume":"229","author":"Serres","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2019.05.001_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jvc.2014.10.004","article-title":"Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension","volume":"17","author":"Soydan","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib31","first-page":"211","article-title":"Evaluation of oscillometric and Doppler ultrasonic methods of indirect blood pressure estimation in conscious dogs","volume":"70","author":"Haberman","year":"2006","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.jvc.2019.05.001_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1939-1676.2007.tb03005.x","article-title":"Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats","volume":"21","author":"Brown","year":"2007","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2460\/javma.2005.226.1864","article-title":"Development and evaluation of a questionnaire for assessing health-related quality of life in dogs with cardiac disease","volume":"226","author":"Freeman","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2019.05.001_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-7843.2008.00299.x","article-title":"Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism","volume":"103","author":"Dias-Junior","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jvc.2019.05.001_bib35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvc.2019.05.001_bib36","first-page":"100","article-title":"A retrospective review of infants receiving sildenafil","volume":"23","author":"De","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jvc.2019.05.001_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.hlc.2016.11.003","article-title":"Comparing the efficacy of tadalafil versus placebo on pulmonary artery systolic pressure and right ventricular function in patients with beta-thalassaemia intermedia","volume":"26","author":"Jalalian","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jvc.2019.05.001_bib38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijcard.2007.01.046","article-title":"Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients","volume":"125","author":"Tay","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12890-017-0374-x","article-title":"Efficacy of 1, 5, and 20 mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension: a randomized, double-blind study with open-label extension","volume":"17","author":"Vizza","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib40","first-page":"1488","article-title":"Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study","volume":"44","author":"Ghofrani","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib41","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1080\/03007995.2017.1354832","article-title":"Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance","volume":"33","author":"Yamazaki","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jvc.2019.05.001_bib42","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2012.05.004","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study","volume":"60","author":"Oudiz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1017\/S1047951117000981","article-title":"Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts","volume":"27","author":"Sabri","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jvc.2019.05.001_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","article-title":"Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis","volume":"36","author":"Denton","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jvc.2019.05.001_bib45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jvc.2019.05.001_bib46","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.jvc.2019.05.001_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00408-014-9657-7","article-title":"Safety and long-term efficacy of transition from sildenafil to tadalafil due to side effects in patients with pulmonary arterial hypertension","volume":"193","author":"Lichtblau","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.jvc.2019.05.001_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jvc.2015.04.002","article-title":"Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005-2014","volume":"17","author":"Kellihan","year":"2015","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2019.05.001_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1748-5827.2011.01127.x","article-title":"Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome","volume":"52","author":"Nakamura","year":"2011","journal-title":"J Small Anim Pract"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273418302029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273418302029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:37:44Z","timestamp":1761705464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273418302029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":49,"alternative-id":["S1760273418302029"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2019.05.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}